Related Experiment Video
Updated: Aug 22, 2026

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
Kinetics of macrolide action: the josamycin and erythromycin cases
Martin Lovmar1, Tanel Tenson, Måns Ehrenberg
1Department of Cell and Molecular Biology, Molecular Biology Program, BMC, Box 596, Uppsala University, S-75124 Uppsala, Sweden.
Abstract:
Members of the macrolide class of antibiotics inhibit peptide elongation on the ribosome by binding close to the peptidyltransferase center and blocking the peptide exit tunnel in the large ribosomal subunit. We have studied the modes of action of the macrolides josamycin, with a 16-membered lactone ring, and erythromycin, with a 14-membered lactone ring, in a cell-free mRNA translation system with pure components from Escherichia coli. We have found that the average lifetime on the ribosome is 3 h for josamycin and less than 2 min for erythromycin and that the dissociation constants for josamycin and erythromycin binding to the ribosome are 5.5 and 11 nM, respectively. Josamycin slows down formation of the first peptide bond of a nascent peptide in an amino acid-dependent way and completely inhibits formation of the second or third peptide bond, depending on peptide sequence. Erythromycin allows formation of longer peptide chains before the onset of inhibition. Both drugs stimulate the rate constants for drop-off of peptidyl-tRNA from the ribosome. In the josamycin case, drop-off is much faster than drug dissociation, whereas these rate constants are comparable in the erythromycin case. Therefore, at a saturating drug concentration, synthesis of full-length proteins is completely shut down by josamycin but not by erythromycin. It is likely that the bacterio-toxic effects of the drugs are caused by a combination of inhibition of protein elongation, on the one hand, and depletion of the intracellular pools of aminoacyl-tRNAs available for protein synthesis by drop-off and incomplete peptidyl-tRNA hydrolase activity, on the other hand.
Insights
Josamycin, a macrolide antibiotic, binds longer to ribosomes than erythromycin, completely halting protein synthesis. This difference in ribosome binding explains their distinct bactericidal effects, with josamycin being more potent.
Area of Science:
- Molecular Biology
- Microbiology
- Biochemistry
Background:
- Macrolide antibiotics inhibit bacterial protein synthesis by targeting the ribosome.
- Josamycin and erythromycin are macrolides with different lactone ring sizes (16-membered vs. 14-membered).
Purpose of the Study:
- To investigate and compare the modes of action of josamycin and erythromycin on ribosomal peptide elongation.
- To elucidate the mechanisms underlying their differential bactericidal activities.
Main Methods:
- Utilized a cell-free translation system with purified Escherichia coli components.
- Measured ribosome binding, dissociation constants, and peptide bond formation kinetics.
- Analyzed peptidyl-tRNA drop-off rates and their relationship to drug dissociation.
Main Results:
- Josamycin exhibits a significantly longer ribosome residence time (3 h) compared to erythromycin (<2 min).
- Josamycin has a lower dissociation constant (5.5 nM) than erythromycin (11 nM), indicating tighter binding.
- Josamycin completely inhibits protein synthesis at saturating concentrations, while erythromycin allows for longer peptide chains.
- Both drugs increase peptidyl-tRNA drop-off, but this is more pronounced and faster than drug dissociation for josamycin.
Conclusions:
- Josamycin's prolonged ribosome binding and complete inhibition of protein synthesis contribute to its potent bactericidal effect.
- Differential effects on peptide elongation and peptidyl-tRNA stability explain the varying efficacy of these macrolides.
- Bacterial toxicity likely results from inhibited protein elongation and depleted aminoacyl-tRNA pools due to drug-induced drop-off.
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Antimicrobial Effectiveness
Clinical Significance of Antibiotic Resistance
Kinetics of Drug Elimination
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
